C R Bard Inc $139.49

up +0.23


17/4/2014 06:40 PM  |  NYSE : BCR  
Industries : Health Services / Medical Instruments & Supplies
Get Trend Analysis Icon Get BCR Trend Analysis - it has outperformed the S&P 500 by 18%

Partner Headlines

  1. UPDATE: Bank of America Downgrades C.R. Bard on Multiple Factors

    Benzinga
  2. Yacktman Funds Comments on C.R. Bard Inc.

    GuruFocus
  3. Bard Announces $500M Share Repurchase Authorization

    Benzinga
  4. Yacktman Fund Comments on C.R. Bard Inc.

    GuruFocus
  5. Earnings Scheduled For January 30, 2014

    Benzinga
  6. Risk and Cycles: Looking at Buybacks, Debt, Cash

    YCharts
  7. Weekly Insider Sells Highlight: BCR, GLUU, AMT, APOL, JACK

    GuruFocus
  8. Anti-Elitism: Beating The Dividend Aristocrats

    YCharts
  9. UPDATE: Goldman Sachs Upgrades C.R. Bard as Elements Driving Sell Thesis ...

    Benzinga
  10. UPDATE: Piper Jaffray Upgrades C.R. Bard on Improving Organic Growth Profile, ...

    Benzinga
  11. Benzinga's Top Upgrades

    Benzinga
  12. C.R. Bard Rises After Q3 Earnings Beat (BCR)

    Benzinga
  13. Earnings Scheduled For October 22, 2013

    Benzinga
  14. UPDATE: Citigroup Raises PT on C.R. Bard on Adjusted BCR Estimates

    Benzinga
  15. CryoLife Says Will Receive ~$15.1M Related to Purchase of Medafor by CR ...

    Benzinga
  16. Market Wrap For Wednesday, September 4: Markets Increase Slightly As M&As ...

    Benzinga
  17. Benzinga's M&A Chatter for Wednesday September 4, 2013

    Benzinga
  18. Morning Market Movers

    Benzinga
  19. Benzinga's Top Pre-Market Gainers

    Benzinga
  20. UPDATE: Bard to Purchase Rochester Medical at $20/Share, or ~$262M Deal

    Benzinga
  21. UPDATE: Bank of America Raises PT on C.R. Bard Following CEO/CFO Meetings

    Benzinga
  22. St. Jude acquires new tech

    IBD
  23. St. Jude, C.R. Bard Make Medical Device Acquisitions

    IBD
  24. CR Bard Announces Deal to Buy Medafor for $200M; Sees Deal Dilutive to ...

    Benzinga
  25. UPDATE: Citigroup Reiterates Neutral Rating, Lowers PT on C.R. Bard

    Benzinga
  26. UPDATE: BMO Capital Markets Reiterates Market Perform Rating, Lowers PT ...

    Benzinga
  27. UPDATE: C.R. Bard Q4 Profit Rises 13%

    Benzinga
  28. UPDATE: Morgan Stanley Downgrades C.R. Bard to Underweight on Lagging Organic ...

    Benzinga
  29. Donald Yacktman Finds Two Undervalued Companies in His Most Bought, In-Favor ...

    GuruFocus
  30. Medical Device Makers: Repeal the New Tax!

    FoxBusiness
  31. Benzinga's Top Initiations

    Benzinga
  32. Steven Cohen's SAC Capital Advisors Q3 Updates: Buys Fossil, Fastenal Company ...

    GuruFocus
  33. C.R. Bard Inc. Reports Operating Results (10-Q)

    GuruFocus
  34. Bard Acquires Neomend For $140M

    Benzinga
  35. Earnings Scheduled For October 23, 2012

    Benzinga
  36. Yacktman at Texas Lutheran - Notes

    GuruFocus
  37. Medtronic Inc. (MDT) Dividend Stock Analysis

    GuruFocus
  38. UPDATE: Bank of America Merrill Lynch Reiterates Neutral Rating, Raises ...

    Benzinga
  39. C.R. Bard Inc. (BCR) Chairman and CEO Timothy M Ring sells 21,923 Shares

    GuruFocus
  40. C.R. Bard Inc. (BCR) President and COO John H Weiland sells 15,554 Shares

    GuruFocus
  41. C.R. Bard Inc. Reports Operating Results (10-Q)

    GuruFocus
  42. Health Care Sector Wrap

    FoxBusiness
  43. Earnings Scheduled For July 25

    Benzinga
  44. Three Safe Dividend-Paying Stocks Releasing Earnings Next Week

    Benzinga
  45. UPDATE: Piper Jaffray Raises PT to $102 on CR Bard on Higher Large-Cap ...

    Benzinga
  46. Valuing Donald Yacktman's Portfolio: The Peter Lynch Fair Value

    GuruFocus
  47. Valuing Donald Yacktman's Portfolio - The Peter Lynch Fair Value

    GuruFocus
  48. Five Stocks That Have Boosted Dividends for Five Consecutive Years

    Benzinga
  49. Five Consistent Dividend Payers Boosting Distributions

    GuruFocus
  50. The Best Stocks With Dividend Growth From Last Week (June 11 - June 17, ...

    GuruFocus
Trading Center